Ani Pharmaceuticals (ANIP) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Ani Pharmaceuticals (ANIP) over the last 17 years, with Q3 2025 value amounting to 0.36.
- Ani Pharmaceuticals' Equity Ratio fell 948.62% to 0.36 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.36, marking a year-over-year decrease of 948.62%. This contributed to the annual value of 0.31 for FY2024, which is 4467.83% down from last year.
- As of Q3 2025, Ani Pharmaceuticals' Equity Ratio stood at 0.36, which was down 948.62% from 0.33 recorded in Q2 2025.
- Over the past 5 years, Ani Pharmaceuticals' Equity Ratio peaked at 0.57 during Q4 2023, and registered a low of 0.31 during Q4 2024.
- For the 5-year period, Ani Pharmaceuticals' Equity Ratio averaged around 0.45, with its median value being 0.46 (2022).
- In the last 5 years, Ani Pharmaceuticals' Equity Ratio soared by 3281.99% in 2022 and then tumbled by 4467.83% in 2024.
- Quarter analysis of 5 years shows Ani Pharmaceuticals' Equity Ratio stood at 0.5 in 2021, then increased by 5.72% to 0.53 in 2022, then increased by 6.97% to 0.57 in 2023, then crashed by 44.68% to 0.31 in 2024, then rose by 14.23% to 0.36 in 2025.
- Its Equity Ratio was 0.36 in Q3 2025, compared to 0.33 in Q2 2025 and 0.32 in Q1 2025.